REDDY BANDI PARTHASARADHI has a total of 22 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ALGOMEDIX INC, MOEHS IBERICA S L and PETRUKHIN KONSTANTIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods | |
#5 | Sugars | |
#6 | Special acyclic compounds | |
#7 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Reddy Bandi Parthasaradhi | 22 |
#2 | Reddy Kura Rathnakar | 18 |
#3 | Reddy Dasari Muralidhara | 17 |
#4 | Krishna Bandi Vamsi | 13 |
#5 | Reddy Rapolu Raji | 9 |
#6 | Rao Thungathurthy Srinivasa | 6 |
#7 | Khadgapathi Podili | 4 |
#8 | Reddy Kesireddy Subash Chander | 4 |
#9 | Reddy Goli Kamalakar | 3 |
#10 | Reddy Adulla Venkat Narsimha | 2 |
Publication | Filing date | Title |
---|---|---|
US2014350038A1 | Rilpivirine hydrochloride | |
US2014107337A1 | Process for fosaprepitant | |
US2013211091A1 | Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form | |
US2012225121A1 | Bioequivalent formulation of efavirenz | |
US2012178930A1 | Polymorphs of raltegravir potassium | |
US2009233879A1 | Nucleoside derivatives |